Treatment of cocaine addiction
US5189064A · kind A · utility
49Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 14, 1990 |
| Grant date | Feb 23, 1993 |
| Priority date | — |
| Expiry date | May 14, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/405
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cocaine addiction is treated by administration of an endorphinase or enkephalinase inhibitor, and optionally, a dopamine precursor, or a serotonin precursor, a GABA precursor, or an endorphin or enkephalin releaser. These components promote restoration of normal neurotransmitter function and are non-addictive. Use of the dopamine precursors L-phenylalanine or L-tyrosine, the enkephalinase inhibitor D-phenylalanine and/or the serotonin precursor L-tryptophan is especially preferred.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.